Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Monday
May 09
16:45 - 17:45
Room D1
CNS
Danielle Eekers, The Netherlands;
Maarten Lambrecht, Belgium
Proffered Papers
Clinical
17:15 - 17:25
Impact of radiation doses to parahippocampal gyrus and amygdala on memory in pituitary adenomas
OC-0927

Abstract

Impact of radiation doses to parahippocampal gyrus and amygdala on memory in pituitary adenomas
Authors:

Archya Dasgupta1, Ajay Thomas Alex1, Arpita Sahu2, Ujjwal Agarwal2, Abhishek Chatterjee1, Savita Goswami3, Utpal Gaikwad1, Nazia Bano1, Vikas Singh4, Prakash Shetty4, Aliasgar Moiyadi4, Ayushi Sahay5, Epari Sridhar5, Amitkumar Choudhari2, Kajari Bhattacharya2, Rajesh Kinhikar6, Rakesh Jalali1, Tejpal Gupta1, Jayant Sastri Goda1

1Tata Memorial Centre, Radiation Oncology, Mumbai, India; 2Tata Memorial Centre, Radiodiagnosis, Mumbai, India; 3Tata Memorial Centre, Neuropsychology, Mumbai, India; 4Tata Memorial Centre, Neurosurgery, Mumbai, India; 5Tata Memorial Centre, Neuropathology, Mumbai, India; 6Tata Memorial Centre, Medical Physics, Mumbai, India

Show Affiliations
Purpose or Objective

Radiation doses to the hippocampus have been linked to neurocognitive outcomes in primary brain tumors and brain metastasis treated with radiotherapy (RT). Hippocampus has extensive neural connections to the surrounding structures, including the amygdala and parahippocampal gyrus (PG), which are known to play a crucial role in emotional response and memory encoding. However, clinical data is lacking on the impact of RT doses on these structures, which led to the current study investigating the effect of doses on memory functions.

Material and Methods

Adults (>18 years) with pituitary adenoma receiving intensity-modulated radiotherapy RT (45Gy/25fractions/5weeks) were accrued on a phase 2 prospective study. No definitive dose-constraints were applied to the hippocampus, amygdala, or PG, although as low as reasonably achievable (ALARA) principle was followed. The amygdala and PG on the left and right sides were drawn on T1-weighted 3D-FSPGR (slice thickness 1 mm) based on the consensus of two neuroradiologists. Dose parameters were extracted for the individual volumes. A dedicated neuropsychologist performed the memory evaluation using Wechsler Memory Scale, pre-RT, at 6 &18 months post-RT. We evaluated the 18-month scores, and a drop > 5% was considered clinically relevant. Shapiro-Wilk test was used for normality of data. Independent t-test and Mann-Whitney tests were done to correlate memory quotient (MQ) with sub-volume dosimetric data. A p-value of <0.05 was considered statistically significant. 

Results

Nineteen patients were analyzed for dose correlation with memory function. Nine patients had a drop of >5% from the baseline. Of the four structure sets from both sides, only the dose-parameters from the left amygdala had a significant correlation with the memory outcomes at 18 months. The mean values of doses to the left amygdala for the two outcome groups (>5% vs ≤ 5% drop) were: mean dose 37.8 Gy vs 31.2 Gy (p=0.05), D30 40.1 Gy vs 33.3 Gy (p=0.04), D40 39.1 Gy vs 32.1 Gy (p=0.04), and D60 37.0 Gy vs 29.8 Gy (p=0.04).




Conclusion

This is the first exploratory clinical study to demonstrate that the dose to the left amygdala correlated with memory outcomes. This study provides further opportunities to explore the dose-volume parameters of the amygdala and definitive constraints can be used along with the hippocampus to preserve memory function following RT.